Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07698210 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of LY4178256 in Healthy Participants

Name: A Study of LY4178256 in Healthy Participants — clinical trial record (NCT07698210)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 1

SponsorEli Lilly and Company

Started2026-07-16

View on ClinicalTrials.gov ↗

The main purpose of this study is to evaluate how well LY4178256 is tolerated and what side effects may occur in healthy participants. Blood tests will be performed to check how much LY4178256 gets into the bloodstream and how long it takes the body to eliminate it. For each participant, the study will last about 7 months and will include either 7 or 12 visits depending on the assigned treatment.

Amendment history 1 change detected by DataLookout

2026-08-21

Recruitment opened

Trial Details

NCT Number	NCT07698210
Lead Sponsor	Eli Lilly and Company
Conditions	Healthy Volunteers
Enrollment	88 participants
Start Date	2026-07-16
Primary Completion	2028-03 (estimated)
Study Completion	2028-03 (estimated)
Updated on ClinicalTrials.gov	2026-08-20